Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:antigens, ly'
(id=6750587 ; fe=en:antigens, ly ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1868 creation date=2017-06-22 touchdate=2025-12-02 05:04:57.000)
≈ 63 relations sortantes

  1. en:antigens, ly -- r_associated #0: 42 / 1 -> en:thymic shared antigen-1
    n1=en:antigens, ly | n2=en:thymic shared antigen-1 | rel=r_associated | relid=0 | w=42
  2. en:antigens, ly -- r_associated #0: 42 / 1 -> en:twit protein, drosophila
    n1=en:antigens, ly | n2=en:twit protein, drosophila | rel=r_associated | relid=0 | w=42
  3. en:antigens, ly -- r_associated #0: 41 / 0.976 -> en:antigens, differentiation, b-lymphocyte
    n1=en:antigens, ly | n2=en:antigens, differentiation, b-lymphocyte | rel=r_associated | relid=0 | w=41
  4. en:antigens, ly -- r_associated #0: 40 / 0.952 -> en:ly-49w1 receptor
    n1=en:antigens, ly | n2=en:ly-49w1 receptor | rel=r_associated | relid=0 | w=40
  5. en:antigens, ly -- r_associated #0: 38 / 0.905 -> en:ly6i protein, mouse
    n1=en:antigens, ly | n2=en:ly6i protein, mouse | rel=r_associated | relid=0 | w=38
  6. en:antigens, ly -- r_associated #0: 35 / 0.833 -> en:aspects of radiation effects
    n1=en:antigens, ly | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=35
  7. en:antigens, ly -- r_associated #0: 35 / 0.833 -> en:chemical aspects
    n1=en:antigens, ly | n2=en:chemical aspects | rel=r_associated | relid=0 | w=35
  8. en:antigens, ly -- r_associated #0: 35 / 0.833 -> en:ly7 protein, mouse
    n1=en:antigens, ly | n2=en:ly7 protein, mouse | rel=r_associated | relid=0 | w=35
  9. en:antigens, ly -- r_associated #0: 35 / 0.833 -> en:lypd6 protein, human
    n1=en:antigens, ly | n2=en:lypd6 protein, human | rel=r_associated | relid=0 | w=35
  10. en:antigens, ly -- r_associated #0: 35 / 0.833 -> en:mechanism of action qualifier
    n1=en:antigens, ly | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=35
  11. en:antigens, ly -- r_associated #0: 35 / 0.833 -> en:taxonomic
    n1=en:antigens, ly | n2=en:taxonomic | rel=r_associated | relid=0 | w=35
  12. en:antigens, ly -- r_associated #0: 35 / 0.833 -> en:tpre
    n1=en:antigens, ly | n2=en:tpre | rel=r_associated | relid=0 | w=35
  13. en:antigens, ly -- r_associated #0: 34 / 0.81 -> en:cluster of differentiation
    n1=en:antigens, ly | n2=en:cluster of differentiation | rel=r_associated | relid=0 | w=34
  14. en:antigens, ly -- r_associated #0: 34 / 0.81 -> en:immunology aspects
    n1=en:antigens, ly | n2=en:immunology aspects | rel=r_associated | relid=0 | w=34
  15. en:antigens, ly -- r_associated #0: 34 / 0.81 -> en:in blood
    n1=en:antigens, ly | n2=en:in blood | rel=r_associated | relid=0 | w=34
  16. en:antigens, ly -- r_associated #0: 34 / 0.81 -> en:klra10 protein, mouse
    n1=en:antigens, ly | n2=en:klra10 protein, mouse | rel=r_associated | relid=0 | w=34
  17. en:antigens, ly -- r_associated #0: 34 / 0.81 -> en:ly11 protein, mouse
    n1=en:antigens, ly | n2=en:ly11 protein, mouse | rel=r_associated | relid=0 | w=34
  18. en:antigens, ly -- r_associated #0: 34 / 0.81 -> en:metabolic aspects
    n1=en:antigens, ly | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=34
  19. en:antigens, ly -- r_associated #0: 34 / 0.81 -> en:slurp1 protein, human
    n1=en:antigens, ly | n2=en:slurp1 protein, human | rel=r_associated | relid=0 | w=34
  20. en:antigens, ly -- r_associated #0: 34 / 0.81 -> en:stage-specific embryonic antigens
    n1=en:antigens, ly | n2=en:stage-specific embryonic antigens | rel=r_associated | relid=0 | w=34
  21. en:antigens, ly -- r_associated #0: 32 / 0.762 -> en:ly49i antigen
    n1=en:antigens, ly | n2=en:ly49i antigen | rel=r_associated | relid=0 | w=32
  22. en:antigens, ly -- r_associated #0: 32 / 0.762 -> en:slurp-1 protein, rat
    n1=en:antigens, ly | n2=en:slurp-1 protein, rat | rel=r_associated | relid=0 | w=32
  23. en:antigens, ly -- r_associated #0: 31 / 0.738 -> en:antigens, differentiation, myelomonocytic
    n1=en:antigens, ly | n2=en:antigens, differentiation, myelomonocytic | rel=r_associated | relid=0 | w=31
  24. en:antigens, ly -- r_associated #0: 31 / 0.738 -> en:historical aspects qualifier
    n1=en:antigens, ly | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=31
  25. en:antigens, ly -- r_associated #0: 31 / 0.738 -> en:ly-49
    n1=en:antigens, ly | n2=en:ly-49 | rel=r_associated | relid=0 | w=31
  26. en:antigens, ly -- r_associated #0: 31 / 0.738 -> en:ncr1 protein, mouse
    n1=en:antigens, ly | n2=en:ncr1 protein, mouse | rel=r_associated | relid=0 | w=31
  27. en:antigens, ly -- r_associated #0: 31 / 0.738 -> en:therapeutic use - qualifier
    n1=en:antigens, ly | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=31
  28. en:antigens, ly -- r_associated #0: 31 / 0.738 -> en:ultrastructure
    n1=en:antigens, ly | n2=en:ultrastructure | rel=r_associated | relid=0 | w=31
  29. en:antigens, ly -- r_associated #0: 30 / 0.714 -> en:ly-49l antigen
    n1=en:antigens, ly | n2=en:ly-49l antigen | rel=r_associated | relid=0 | w=30
  30. en:antigens, ly -- r_associated #0: 30 / 0.714 -> en:ly33 protein, mouse
    n1=en:antigens, ly | n2=en:ly33 protein, mouse | rel=r_associated | relid=0 | w=30
  31. en:antigens, ly -- r_associated #0: 30 / 0.714 -> en:ly6a protein, mouse
    n1=en:antigens, ly | n2=en:ly6a protein, mouse | rel=r_associated | relid=0 | w=30
  32. en:antigens, ly -- r_associated #0: 30 / 0.714 -> en:ly6k protein, mouse
    n1=en:antigens, ly | n2=en:ly6k protein, mouse | rel=r_associated | relid=0 | w=30
  33. en:antigens, ly -- r_associated #0: 30 / 0.714 -> en:poisoning aspects
    n1=en:antigens, ly | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=30
  34. en:antigens, ly -- r_associated #0: 29 / 0.69 -> en:antigens, differentiation
    n1=en:antigens, ly | n2=en:antigens, differentiation | rel=r_associated | relid=0 | w=29
  35. en:antigens, ly -- r_associated #0: 29 / 0.69 -> en:contraindications aspect
    n1=en:antigens, ly | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=29
  36. en:antigens, ly -- r_associated #0: 29 / 0.69 -> en:in cerebrospinal fluid
    n1=en:antigens, ly | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=29
  37. en:antigens, ly -- r_associated #0: 29 / 0.69 -> en:in urine
    n1=en:antigens, ly | n2=en:in urine | rel=r_associated | relid=0 | w=29
  38. en:antigens, ly -- r_associated #0: 29 / 0.69 -> en:klrb1c protein, mouse
    n1=en:antigens, ly | n2=en:klrb1c protein, mouse | rel=r_associated | relid=0 | w=29
  39. en:antigens, ly -- r_associated #0: 29 / 0.69 -> en:ly6g antigen, mouse
    n1=en:antigens, ly | n2=en:ly6g antigen, mouse | rel=r_associated | relid=0 | w=29
  40. en:antigens, ly -- r_associated #0: 28 / 0.667 -> en:bioformation
    n1=en:antigens, ly | n2=en:bioformation | rel=r_associated | relid=0 | w=28
  41. en:antigens, ly -- r_associated #0: 28 / 0.667 -> en:drug effect
    n1=en:antigens, ly | n2=en:drug effect | rel=r_associated | relid=0 | w=28
  42. en:antigens, ly -- r_associated #0: 28 / 0.667 -> en:ly108 protein, mouse
    n1=en:antigens, ly | n2=en:ly108 protein, mouse | rel=r_associated | relid=0 | w=28
  43. en:antigens, ly -- r_associated #0: 28 / 0.667 -> en:ly6 protein, mouse
    n1=en:antigens, ly | n2=en:ly6 protein, mouse | rel=r_associated | relid=0 | w=28
  44. en:antigens, ly -- r_associated #0: 28 / 0.667 -> en:ly6g6e protein, mouse
    n1=en:antigens, ly | n2=en:ly6g6e protein, mouse | rel=r_associated | relid=0 | w=28
  45. en:antigens, ly -- r_associated #0: 28 / 0.667 -> en:sslp-1 protein, mouse
    n1=en:antigens, ly | n2=en:sslp-1 protein, mouse | rel=r_associated | relid=0 | w=28
  46. en:antigens, ly -- r_associated #0: 27 / 0.643 -> en:analysis aspect
    n1=en:antigens, ly | n2=en:analysis aspect | rel=r_associated | relid=0 | w=27
  47. en:antigens, ly -- r_associated #0: 27 / 0.643 -> en:genetic aspects
    n1=en:antigens, ly | n2=en:genetic aspects | rel=r_associated | relid=0 | w=27
  48. en:antigens, ly -- r_associated #0: 27 / 0.643 -> en:ly 44 antigen
    n1=en:antigens, ly | n2=en:ly 44 antigen | rel=r_associated | relid=0 | w=27
  49. en:antigens, ly -- r_associated #0: 27 / 0.643 -> en:ly-6c antigen, mouse
    n1=en:antigens, ly | n2=en:ly-6c antigen, mouse | rel=r_associated | relid=0 | w=27
  50. en:antigens, ly -- r_associated #0: 27 / 0.643 -> en:ly6d protein, mouse
    n1=en:antigens, ly | n2=en:ly6d protein, mouse | rel=r_associated | relid=0 | w=27
  51. en:antigens, ly -- r_associated #0: 27 / 0.643 -> en:ly6k protein, human
    n1=en:antigens, ly | n2=en:ly6k protein, human | rel=r_associated | relid=0 | w=27
  52. en:antigens, ly -- r_associated #0: 27 / 0.643 -> en:lypd7 protein, human
    n1=en:antigens, ly | n2=en:lypd7 protein, human | rel=r_associated | relid=0 | w=27
  53. en:antigens, ly -- r_associated #0: 27 / 0.643 -> en:toxicity aspects
    n1=en:antigens, ly | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=27
  54. en:antigens, ly -- r_associated #0: 26 / 0.619 -> en:antigens, differentiation, t-lymphocyte
    n1=en:antigens, ly | n2=en:antigens, differentiation, t-lymphocyte | rel=r_associated | relid=0 | w=26
  55. en:antigens, ly -- r_associated #0: 26 / 0.619 -> en:aspects of adverse effects
    n1=en:antigens, ly | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=26
  56. en:antigens, ly -- r_associated #0: 26 / 0.619 -> en:exposure as collected domain
    n1=en:antigens, ly | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=26
  57. en:antigens, ly -- r_associated #0: 26 / 0.619 -> en:ly-49w receptor
    n1=en:antigens, ly | n2=en:ly-49w receptor | rel=r_associated | relid=0 | w=26
  58. en:antigens, ly -- r_associated #0: 26 / 0.619 -> en:ly-49w2 receptor
    n1=en:antigens, ly | n2=en:ly-49w2 receptor | rel=r_associated | relid=0 | w=26
  59. en:antigens, ly -- r_associated #0: 26 / 0.619 -> en:ncr3 protein, mouse
    n1=en:antigens, ly | n2=en:ncr3 protein, mouse | rel=r_associated | relid=0 | w=26
  60. en:antigens, ly -- r_associated #0: 26 / 0.619 -> en:physiological aspects
    n1=en:antigens, ly | n2=en:physiological aspects | rel=r_associated | relid=0 | w=26
  61. en:antigens, ly -- r_associated #0: 26 / 0.619 -> en:slurp-1 protein, mouse
    n1=en:antigens, ly | n2=en:slurp-1 protein, mouse | rel=r_associated | relid=0 | w=26
  62. en:antigens, ly -- r_associated #0: 20 / 0.476 -> effet d'un médicament
    n1=en:antigens, ly | n2=effet d'un médicament | rel=r_associated | relid=0 | w=20
  63. en:antigens, ly -- r_associated #0: 20 / 0.476 -> en:lymphocyte antigen 6k, human
    n1=en:antigens, ly | n2=en:lymphocyte antigen 6k, human | rel=r_associated | relid=0 | w=20
≈ 64 relations entrantes

  1. effet d'un médicament --- r_associated #0: 53 --> en:antigens, ly
    n1=effet d'un médicament | n2=en:antigens, ly | rel=r_associated | relid=0 | w=53
  2. en:drug effect --- r_associated #0: 51 --> en:antigens, ly
    n1=en:drug effect | n2=en:antigens, ly | rel=r_associated | relid=0 | w=51
  3. en:twit protein, drosophila --- r_associated #0: 41 --> en:antigens, ly
    n1=en:twit protein, drosophila | n2=en:antigens, ly | rel=r_associated | relid=0 | w=41
  4. en:ly6d protein, mouse --- r_associated #0: 40 --> en:antigens, ly
    n1=en:ly6d protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=40
  5. en:ly 44 antigen --- r_associated #0: 39 --> en:antigens, ly
    n1=en:ly 44 antigen | n2=en:antigens, ly | rel=r_associated | relid=0 | w=39
  6. en:ly6g antigen, mouse --- r_associated #0: 39 --> en:antigens, ly
    n1=en:ly6g antigen, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=39
  7. en:ly-49w receptor --- r_associated #0: 38 --> en:antigens, ly
    n1=en:ly-49w receptor | n2=en:antigens, ly | rel=r_associated | relid=0 | w=38
  8. en:ly108 protein, mouse --- r_associated #0: 35 --> en:antigens, ly
    n1=en:ly108 protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=35
  9. en:ly-49l antigen --- r_associated #0: 34 --> en:antigens, ly
    n1=en:ly-49l antigen | n2=en:antigens, ly | rel=r_associated | relid=0 | w=34
  10. en:ly6 protein, mouse --- r_associated #0: 34 --> en:antigens, ly
    n1=en:ly6 protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=34
  11. en:ly6a protein, mouse --- r_associated #0: 32 --> en:antigens, ly
    n1=en:ly6a protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=32
  12. en:ly7 protein, mouse --- r_associated #0: 32 --> en:antigens, ly
    n1=en:ly7 protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=32
  13. en:mechanism of action qualifier --- r_associated #0: 32 --> en:antigens, ly
    n1=en:mechanism of action qualifier | n2=en:antigens, ly | rel=r_associated | relid=0 | w=32
  14. en:ncr3 protein, mouse --- r_associated #0: 32 --> en:antigens, ly
    n1=en:ncr3 protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=32
  15. en:sslp-1 protein, mouse --- r_associated #0: 32 --> en:antigens, ly
    n1=en:sslp-1 protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=32
  16. en:bioformation --- r_associated #0: 31 --> en:antigens, ly
    n1=en:bioformation | n2=en:antigens, ly | rel=r_associated | relid=0 | w=31
  17. en:klrb1c protein, mouse --- r_associated #0: 31 --> en:antigens, ly
    n1=en:klrb1c protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=31
  18. en:ly-6c antigen, mouse --- r_associated #0: 31 --> en:antigens, ly
    n1=en:ly-6c antigen, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=31
  19. en:ly33 protein, mouse --- r_associated #0: 31 --> en:antigens, ly
    n1=en:ly33 protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=31
  20. en:ncr1 protein, mouse --- r_associated #0: 31 --> en:antigens, ly
    n1=en:ncr1 protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=31
  21. en:chemical aspects --- r_associated #0: 30 --> en:antigens, ly
    n1=en:chemical aspects | n2=en:antigens, ly | rel=r_associated | relid=0 | w=30
  22. en:contraindications aspect --- r_associated #0: 30 --> en:antigens, ly
    n1=en:contraindications aspect | n2=en:antigens, ly | rel=r_associated | relid=0 | w=30
  23. en:exposure as collected domain --- r_associated #0: 30 --> en:antigens, ly
    n1=en:exposure as collected domain | n2=en:antigens, ly | rel=r_associated | relid=0 | w=30
  24. en:ly-49 --- r_associated #0: 30 --> en:antigens, ly
    n1=en:ly-49 | n2=en:antigens, ly | rel=r_associated | relid=0 | w=30
  25. en:lypd7 protein, human --- r_associated #0: 30 --> en:antigens, ly
    n1=en:lypd7 protein, human | n2=en:antigens, ly | rel=r_associated | relid=0 | w=30
  26. en:ultrastructure --- r_associated #0: 30 --> en:antigens, ly
    n1=en:ultrastructure | n2=en:antigens, ly | rel=r_associated | relid=0 | w=30
  27. en:antigens, differentiation --- r_associated #0: 29 --> en:antigens, ly
    n1=en:antigens, differentiation | n2=en:antigens, ly | rel=r_associated | relid=0 | w=29
  28. en:antigens, differentiation, t-lymphocyte --- r_associated #0: 29 --> en:antigens, ly
    n1=en:antigens, differentiation, t-lymphocyte | n2=en:antigens, ly | rel=r_associated | relid=0 | w=29
  29. en:ly-49w1 receptor --- r_associated #0: 29 --> en:antigens, ly
    n1=en:ly-49w1 receptor | n2=en:antigens, ly | rel=r_associated | relid=0 | w=29
  30. en:ly6i protein, mouse --- r_associated #0: 29 --> en:antigens, ly
    n1=en:ly6i protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=29
  31. en:ly6k protein, mouse --- r_associated #0: 29 --> en:antigens, ly
    n1=en:ly6k protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=29
  32. en:lypd6 protein, human --- r_associated #0: 29 --> en:antigens, ly
    n1=en:lypd6 protein, human | n2=en:antigens, ly | rel=r_associated | relid=0 | w=29
  33. en:slurp-1 protein, rat --- r_associated #0: 29 --> en:antigens, ly
    n1=en:slurp-1 protein, rat | n2=en:antigens, ly | rel=r_associated | relid=0 | w=29
  34. en:toxicity aspects --- r_associated #0: 29 --> en:antigens, ly
    n1=en:toxicity aspects | n2=en:antigens, ly | rel=r_associated | relid=0 | w=29
  35. en:immunology aspects --- r_associated #0: 28 --> en:antigens, ly
    n1=en:immunology aspects | n2=en:antigens, ly | rel=r_associated | relid=0 | w=28
  36. en:ly-49w2 receptor --- r_associated #0: 28 --> en:antigens, ly
    n1=en:ly-49w2 receptor | n2=en:antigens, ly | rel=r_associated | relid=0 | w=28
  37. en:physiological aspects --- r_associated #0: 28 --> en:antigens, ly
    n1=en:physiological aspects | n2=en:antigens, ly | rel=r_associated | relid=0 | w=28
  38. en:slurp1 protein, human --- r_associated #0: 28 --> en:antigens, ly
    n1=en:slurp1 protein, human | n2=en:antigens, ly | rel=r_associated | relid=0 | w=28
  39. en:taxonomic --- r_associated #0: 28 --> en:antigens, ly
    n1=en:taxonomic | n2=en:antigens, ly | rel=r_associated | relid=0 | w=28
  40. en:antigens, differentiation, myelomonocytic --- r_associated #0: 27 --> en:antigens, ly
    n1=en:antigens, differentiation, myelomonocytic | n2=en:antigens, ly | rel=r_associated | relid=0 | w=27
  41. en:ly49i antigen --- r_associated #0: 27 --> en:antigens, ly
    n1=en:ly49i antigen | n2=en:antigens, ly | rel=r_associated | relid=0 | w=27
  42. en:stage-specific embryonic antigens --- r_associated #0: 27 --> en:antigens, ly
    n1=en:stage-specific embryonic antigens | n2=en:antigens, ly | rel=r_associated | relid=0 | w=27
  43. en:therapeutic use - qualifier --- r_associated #0: 27 --> en:antigens, ly
    n1=en:therapeutic use - qualifier | n2=en:antigens, ly | rel=r_associated | relid=0 | w=27
  44. en:tpre --- r_associated #0: 27 --> en:antigens, ly
    n1=en:tpre | n2=en:antigens, ly | rel=r_associated | relid=0 | w=27
  45. en:cluster of differentiation --- r_associated #0: 26 --> en:antigens, ly
    n1=en:cluster of differentiation | n2=en:antigens, ly | rel=r_associated | relid=0 | w=26
  46. en:klra10 protein, mouse --- r_associated #0: 26 --> en:antigens, ly
    n1=en:klra10 protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=26
  47. en:ly11 protein, mouse --- r_associated #0: 26 --> en:antigens, ly
    n1=en:ly11 protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=26
  48. en:ly6g6e protein, mouse --- r_associated #0: 26 --> en:antigens, ly
    n1=en:ly6g6e protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=26
  49. en:lymphocyte antigen 6k, human --- r_associated #0: 26 --> en:antigens, ly
    n1=en:lymphocyte antigen 6k, human | n2=en:antigens, ly | rel=r_associated | relid=0 | w=26
  50. en:slurp-1 protein, mouse --- r_associated #0: 26 --> en:antigens, ly
    n1=en:slurp-1 protein, mouse | n2=en:antigens, ly | rel=r_associated | relid=0 | w=26
  51. en:thymic shared antigen-1 --- r_associated #0: 26 --> en:antigens, ly
    n1=en:thymic shared antigen-1 | n2=en:antigens, ly | rel=r_associated | relid=0 | w=26
  52. en:in blood --- r_associated #0: 25 --> en:antigens, ly
    n1=en:in blood | n2=en:antigens, ly | rel=r_associated | relid=0 | w=25
  53. en:historical aspects qualifier --- r_associated #0: 24 --> en:antigens, ly
    n1=en:historical aspects qualifier | n2=en:antigens, ly | rel=r_associated | relid=0 | w=24
  54. en:in urine --- r_associated #0: 24 --> en:antigens, ly
    n1=en:in urine | n2=en:antigens, ly | rel=r_associated | relid=0 | w=24
  55. en:aspects of adverse effects --- r_associated #0: 23 --> en:antigens, ly
    n1=en:aspects of adverse effects | n2=en:antigens, ly | rel=r_associated | relid=0 | w=23
  56. en:genetic aspects --- r_associated #0: 23 --> en:antigens, ly
    n1=en:genetic aspects | n2=en:antigens, ly | rel=r_associated | relid=0 | w=23
  57. en:metabolic aspects --- r_associated #0: 23 --> en:antigens, ly
    n1=en:metabolic aspects | n2=en:antigens, ly | rel=r_associated | relid=0 | w=23
  58. en:aspects of radiation effects --- r_associated #0: 22 --> en:antigens, ly
    n1=en:aspects of radiation effects | n2=en:antigens, ly | rel=r_associated | relid=0 | w=22
  59. en:poisoning aspects --- r_associated #0: 22 --> en:antigens, ly
    n1=en:poisoning aspects | n2=en:antigens, ly | rel=r_associated | relid=0 | w=22
  60. en:analysis aspect --- r_associated #0: 21 --> en:antigens, ly
    n1=en:analysis aspect | n2=en:antigens, ly | rel=r_associated | relid=0 | w=21
  61. en:antigens, differentiation, b-lymphocyte --- r_associated #0: 21 --> en:antigens, ly
    n1=en:antigens, differentiation, b-lymphocyte | n2=en:antigens, ly | rel=r_associated | relid=0 | w=21
  62. en:in cerebrospinal fluid --- r_associated #0: 21 --> en:antigens, ly
    n1=en:in cerebrospinal fluid | n2=en:antigens, ly | rel=r_associated | relid=0 | w=21
  63. en:ly6k protein, human --- r_associated #0: 21 --> en:antigens, ly
    n1=en:ly6k protein, human | n2=en:antigens, ly | rel=r_associated | relid=0 | w=21
  64. taxinomique --- r_associated #0: 10 --> en:antigens, ly
    n1=taxinomique | n2=en:antigens, ly | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr